Results 231 to 240 of about 20,698 (251)

Semaglutide

Reactions Weekly
Pius Fasinu, Tatjana Coric, Teresa Wilborn   +2 more
  +35 more sources

Semaglutide as a promising antiobesity drug

Obesity Reviews, 2019
Semaglutide is a glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) with a long elimination half‐life, allowing subcutaneous (sc) administration once per week.
Dimitrios N Kiortsis, Georgios A Christou, John Edward Blundell   +2 more
exaly   +2 more sources

Semaglutide

Reactions Weekly, 2023
  +5 more sources

Semaglutid

pharma-kritik, 2019
Semaglutid ist ein weiterer GLP-1-Rezeptoragonist, der nur einmal wöchentlich injiziert werden muss und wie z.B. Liraglutid makrovaskuläre Komplikationen reduziert. Das Nutzen/Risiko-Verhältnis einer chronischen Verabreichung ist noch nicht definitiv geklärt.
openaire   +1 more source

Cyanocobalamin/semaglutide/semaglutide

Reactions Weekly, 2023
openaire   +1 more source

Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER

Circulation, 2022
Bernard Zinman, Ahmed M Shaman
exaly  

Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy

Journal of Clinical Anesthesia, 2023
Anthony M-H Ho
exaly  

Does Semaglutide Use Decrease Complications and Costs Following Total Knee Arthroplasty?

Journal of Arthroplasty, 2023
Vincent Yao, Orry Erez
exaly  

Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program

Diabetes Care, 2022
Carel le Roux, Ildiko Lingvay, Juan Frias   +2 more
exaly